These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27913753)

  • 1. Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients.
    Martínez GJ; Barraclough JY; Nakhla S; Kienzle V; Robertson S; Mallat Z; Celermajer DS; Patel S
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27913753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTH- and cortisol-associated neutrophil modulation in coronary artery disease patients undergoing stent implantation.
    Keresztes M; Horváth T; Ocsovszki I; Földesi I; Serfőző G; Boda K; Ungi I
    PLoS One; 2013; 8(8):e71902. PubMed ID: 23967262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in microparticle release in patients with acute coronary syndrome and stable angina.
    Biasucci LM; Porto I; Di Vito L; De Maria GL; Leone AM; Tinelli G; Tritarelli A; Di Rocco G; Snider F; Capogrossi MC; Crea F
    Circ J; 2012; 76(9):2174-82. PubMed ID: 22664782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent circulating platelet and endothelial derived microparticle signature may explain on-going pro-thrombogenicity after acute coronary syndrome.
    Koganti S; Eleftheriou D; Gurung R; Hong Y; Brogan P; Rakhit RD
    Thromb Res; 2021 Oct; 206():60-65. PubMed ID: 34418680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
    Vaidya K; Tucker B; Kurup R; Khandkar C; Pandzic E; Barraclough J; Machet J; Misra A; Kavurma M; Martinez G; Rye KA; Cochran BJ; Patel S
    J Am Heart Assoc; 2021 Jan; 10(1):e018993. PubMed ID: 33346683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered human neutrophil FcγRI and FcγRIII but not FcγRII expression is associated with the acute coronary event in patients with coronary artery disease.
    Zhao N; Mi L; Zhang Y; Li N; Xu J; Xia D; Wang J; Wu Y; Liu X
    Coron Artery Dis; 2017 Jan; 28(1):63-69. PubMed ID: 27604056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of hemoglobin scavenger receptor CD163 in accumulated macrophages within filtered debris between acute coronary syndromes and stable angina pectoris.
    Sato T; Kameyama T; Noto T; Ueno H; Inoue H
    Int Heart J; 2015; 56(2):150-6. PubMed ID: 25740391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.
    Dieker J; Tel J; Pieterse E; Thielen A; Rother N; Bakker M; Fransen J; Dijkman HB; Berden JH; de Vries JM; Hilbrands LB; van der Vlag J
    Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome.
    Lu Y; Li L; Yan H; Su Q; Huang J; Fu C
    Int J Cardiol; 2013 Oct; 168(6):5396-404. PubMed ID: 24012161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles in acute coronary syndrome.
    Mavroudis CA; Eleftheriou D; Hong Y; Majumder B; Koganti S; Sapsford R; North J; Lowdell M; Klein N; Brogan P; Rakhit RD
    Thromb Res; 2017 Aug; 156():109-116. PubMed ID: 28624718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
    Christersson C; Lindahl B; Siegbahn A
    Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
    Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
    Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil infiltration of culprit lesions in acute coronary syndromes.
    Naruko T; Ueda M; Haze K; van der Wal AC; van der Loos CM; Itoh A; Komatsu R; Ikura Y; Ogami M; Shimada Y; Ehara S; Yoshiyama M; Takeuchi K; Yoshikawa J; Becker AE
    Circulation; 2002 Dec; 106(23):2894-900. PubMed ID: 12460868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.
    Montoro-García S; Shantsila E; Tapp LD; López-Cuenca A; Romero AI; Hernández-Romero D; Orenes-Piñero E; Manzano-Fernández S; Valdés M; Marín F; Lip GY
    Atherosclerosis; 2013 Apr; 227(2):313-22. PubMed ID: 23415055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
    Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M
    Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue characteristics of non-culprit plaque in patients with acute coronary syndrome vs. stable angina: a color-coded intravascular ultrasound study.
    Sudo M; Hiro T; Takayama T; Iida K; Nishida T; Fukamachi D; Kawano T; Higuchi Y; Hirayama A
    Cardiovasc Interv Ther; 2016 Jan; 31(1):42-50. PubMed ID: 26188645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis.
    Moreno JA; Ortega-Gómez A; Delbosc S; Beaufort N; Sorbets E; Louedec L; Esposito-Farèse M; Tubach F; Nicoletti A; Steg PG; Michel JB; Feldman L; Meilhac O
    Eur Heart J; 2012 Jan; 33(2):252-63. PubMed ID: 21606088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coronary plaque composition on cardiac troponin elevation after percutaneous coronary intervention in stable angina pectoris: a computed tomography analysis.
    Watabe H; Sato A; Akiyama D; Kakefuda Y; Adachi T; Ojima E; Hoshi T; Murakoshi N; Ishizu T; Seo Y; Aonuma K
    J Am Coll Cardiol; 2012 May; 59(21):1881-8. PubMed ID: 22595407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent.
    Tomulić V; Gobić D; Lulić D; Židan D; Zaputović L
    Med Hypotheses; 2016 Oct; 95():20-23. PubMed ID: 27692158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina.
    Min PK; Cho M; Hong SY; Kim JY; Choi EY; Yoon YW; Lee BK; Hong BK; Rim SJ; Kwon HM
    PLoS One; 2016; 11(1):e0148128. PubMed ID: 26812147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.